Status:
COMPLETED
Optimizing Surgical Conditions During Laparoscopic Herniotomy With Deep Neuromuscular Blockade
Lead Sponsor:
Herlev Hospital
Conditions:
Laparoscopic Herniotomy
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to investigate surgical work space and surgical conditions in patients scheduled for laparoscopic umbilical, -linea alba and incisional herniotomy. The patients will act a...
Detailed Description
Umbilical herniotomy is a frequent surgical procedure worldwide, and the larger hernia defects are preferably operated by laparoscopic technique. The advantages of the laparoscopic approach are shorte...
Eligibility Criteria
Inclusion
- Patients \> 18 years old
- Elective laparoscopic umbilical herniotomy, incisional herniotomy and linea alba - herniotomy
- Can read and understand Danish
- Informed consent
Exclusion
- Known allergy to sugammadex, rocuronium or mivacurium
- Known homozygous variants in the butyrylcholinesterase gene
- Severe renal disease, defined by S-creatinine\> 0.200 mmol/L, GFR \< 30ml/min or hemodialysis)
- Neuromuscular disease that may interfere with neuromuscular data
- Lactating or pregnant (Women of child bearing potential must take a urine pregnancy test at the day of the operation. The test will be provided by the hospital staff).
- Indication for rapid sequence induction
Key Trial Info
Start Date :
February 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 23 2017
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT02247466
Start Date
February 1 2015
End Date
February 23 2017
Last Update
July 2 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Gentofte Hospital
Hellerup, Capital Region, Denmark, 2900
2
Herlev Hospital
Herlev, Capital Region, Denmark, 2730